Kathy D. Miller
Indiana University Health(US)University of Michigan–Ann Arbor(US)Indiana Cancer Consortium(US)Indiana University Bloomington(US)Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndiana University School of MedicineIndiana University – Purdue University Indianapolis(US)Indiana University(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer(2007)3,043 cited
- → Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer(2005)1,306 cited
- → Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab(2007)932 cited
- → NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4(2003)632 cited
- → Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100(2008)607 cited
- → Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer(2018)